Our top pick for
Beginners
Checkmate Pharmaceuticals Inc is a biotechnology business based in the US. Checkmate Pharmaceuticals shares (CMPI) are listed on the NASDAQ and all prices are listed in US Dollars. Checkmate Pharmaceuticals employs 30 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Checkmate Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CMPI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Checkmate Pharmaceuticals stock price (NASDAQ: CMPI)
Use our graph to track the performance of CMPI stocks over time.Checkmate Pharmaceuticals shares at a glance
Information last updated 2022-07-17.
| Latest market close | $10.50 |
|---|---|
| 52-week range | $2.00 - $10.50 |
| 50-day moving average | $8.60 |
| 200-day moving average | $4.78 |
| Wall St. target price | $12.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.92 |
Buy Checkmate Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 7 of 7
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Checkmate Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Checkmate Pharmaceuticals price performance over time
Historical closes compared with the close of $10.5 from 2022-06-09
| 1 week (2022-09-19) | N/A |
|---|---|
| 1 month (2022-08-26) | N/A |
| 3 months (2022-06-26) | N/A |
| 6 months (2022-03-26) | N/A |
| 1 year (2021-09-30) | 164.48% |
|---|---|
| 2 years (2020-09-30) | -8.77% |
| 3 years (2019-09-26) | N/A |
| 5 years (2017-09-26) | N/A |
Checkmate Pharmaceuticals financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -42.31% |
| Return on equity TTM | -75.44% |
| Profit margin | 0% |
| Book value | $2.54 |
| Market capitalisation | $231.4 million |
TTM: trailing 12 months
Checkmate Pharmaceuticals share dividends
We're not expecting Checkmate Pharmaceuticals to pay a dividend over the next 12 months.
Checkmate Pharmaceuticals overview
Checkmate Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc.
Frequently asked questions
What percentage of Checkmate Pharmaceuticals is owned by insiders or institutions?Currently 4.633% of Checkmate Pharmaceuticals shares are held by insiders and 77.512% by institutions. How many people work for Checkmate Pharmaceuticals?
Latest data suggests 30 work at Checkmate Pharmaceuticals. When does the fiscal year end for Checkmate Pharmaceuticals?
Checkmate Pharmaceuticals's fiscal year ends in December. Where is Checkmate Pharmaceuticals based?
Checkmate Pharmaceuticals's address is: 245 Main Street, Cambridge, MA, United States, 02142 What is Checkmate Pharmaceuticals's ISIN number?
Checkmate Pharmaceuticals's international securities identification number is: US1628181083
More guides on Finder
-
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
-
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
-
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
-
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
-
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
-
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
-
How to buy Lead Real Estate Co. (LRE) stock when it goes public
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
-
How to buy Third Harmonic Bio (THRD) stock
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
-
How to buy LINKBANCORP (LNKB) stock
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
-
Inflation stocks
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.
Ask an Expert